Other
Comprehensive income (loss), including noncontrolling interest
Medtronic Comprehensive income (loss), including noncontrolling interest decreased by 35.8% to $1.10B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 36.0%, from $1.71B to $1.10B.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2018
Last reportedQ3 2026Feb 24, 2026
Metric ID:
nee_comprehensive_income_including_noncontrolling_interestHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.04B | $1.48B | $1.65B | $1.26B | $11.00M | $405.00M | $622.00M | $1.21B | $1.26B | $957.00M | $1.44B | $1.71B | $729.00M | $1.71B | $1.10B |
| QoQ Change | — | +42.2% | +10.9% | -23.7% | -99.1% | >999% | +53.6% | +93.9% | +4.2% | -23.9% | +50.4% | +19.0% | -57.4% | +134.0% | -35.8% |
| YoY Change | — | — | — | +20.3% | -99.3% | -75.4% | -50.4% | >999% | +210.4% | +53.9% | +19.3% | +36.2% | -23.8% | +18.6% | -36.0% |
Range$11.00M – $1.71B
CAGR+1.4%
Avg YoY Growth+911.4%
Median YoY Growth+18.9%
Comprehensive income (loss), including noncontrolling interest at Other Companies
Frequently Asked Questions
- What is Medtronic's comprehensive income (loss), including noncontrolling interest?
- Medtronic (MDT) reported comprehensive income (loss), including noncontrolling interest of $1.10B in Q4 2025.
- How has Medtronic's comprehensive income (loss), including noncontrolling interest changed year-over-year?
- Medtronic's comprehensive income (loss), including noncontrolling interest decreased by 36.0% year-over-year, from $1.71B to $1.10B.